Northern Antibiotics Oy-Product Pipeline Review-2015
Global Markets Direct's, 'Northern Antibiotics Oy-Product Pipeline Review-2015', provides an overview of the Northern Antibiotics Oy's pharmaceutical research and development focus.
This report provides comprehensive information on the current therapeutic developmental pipeline of Northern Antibiotics Oy's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
The report provides brief overview of Northern Antibiotics Oy including business description, key information and facts, and its locations and subsidiaries
The report reviews current pipeline of Northern Antibiotics Oy's human therapeutic division and enlists all their major and minor projects
The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
Special feature on out-licensed and partnered product portfolio
The report summarizes all the dormant and discontinued pipeline projects
Latest company statement
Latest news and deals relating to the Northern Antibiotics Oy's pipeline products
Reasons To Buy
Evaluate Northern Antibiotics Oy's strategic position with total access to detailed information on its product pipeline
Assess the growth potential of Northern Antibiotics Oy in its therapy areas of focus
Identify new drug targets and therapeutic classes in the Northern Antibiotics Oy's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
Develop strategic initiatives by understanding the focus areas of Northern Antibiotics Oy and exploit collaboration and partnership opportunities
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Plan mergers and acquisitions effectively by identifying the most promising pipeline of Northern Antibiotics Oy
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Explore the dormant and discontinued projects of Northern Antibiotics Oy and identify potential opportunities in those areas
Avoid Intellectual Property Rights related issues
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Northern Antibiotics Oy Snapshot 4
Northern Antibiotics Oy Overview 4
Key Information 4
Key Facts 4
Northern Antibiotics Oy-Research and Development Overview 5
Key Therapeutic Areas 5
Northern Antibiotics Oy-Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products-Monotherapy 9
Northern Antibiotics Oy-Pipeline Products Glance 10
Northern Antibiotics Oy-Early Stage Pipeline Products 10
Preclinical Products/Combination Treatment Modalities 10
Northern Antibiotics Oy-Drug Profiles 11
Product Description 11
Mechanism of Action 11
R&D Progress 11
Product Description 13
Mechanism of Action 13
R&D Progress 13
Product Description 14
Mechanism of Action 14
R&D Progress 14
Northern Antibiotics Oy-Pipeline Analysis 15
Northern Antibiotics Oy-Pipeline Products by Target 15
Northern Antibiotics Oy-Pipeline Products by Molecule Type 16
Northern Antibiotics Oy-Pipeline Products by Mechanism of Action 17
Northern Antibiotics Oy-Locations And Subsidiaries 18
Head Office 18
Secondary Research 19
Primary Research 19
Expert Panel Validation 19
Contact Us 19
List of Tables
Northern Antibiotics Oy, Key Information 4
Northern Antibiotics Oy, Key Facts 4
Northern Antibiotics Oy-Pipeline by Indication, 2015 7
Northern Antibiotics Oy-Pipeline by Stage of Development, 2015 8
Northern Antibiotics Oy-Monotherapy Products in Pipeline, 2015 9
Northern Antibiotics Oy-Preclinical, 2015 10
Northern Antibiotics Oy-Pipeline by Target, 2015 15
Northern Antibiotics Oy-Pipeline by Molecule Type, 2015 16
Northern Antibiotics Oy-Pipeline Products by Mechanism of Action, 2015 17
List of Figures
Northern Antibiotics Oy-Pipeline by Top 10 Indication, 2015 6
Northern Antibiotics Oy-Pipeline by Top 10 Molecule Type, 2015 16
Single User License:
Corporate User License:
Current R&D Portfolio of Northern Antibiotics Oy; Northern Antibiotics Oy - Key Therapeutics; Northern Antibiotics Oy - Pipeline Overview and Promising Molecules; Northern Antibiotics Oy - News; Northern Antibiotics Oy - Latest Updates; Northern Antibiotics Oy - Pipeline; Northern Antibiotics Oy - Discontinued/Dormant Projects
select a license
NEWSLETTER BY CATEGORY
Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed... "President, VPP E-Data Services, VPP E-Data Services"
The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements.... "Senior Associate, Booz Allen Hamilton"
This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"
I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"
While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"